Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Adtalem Global Education Inc. (ATGE : NYSE)
 
 • Company Description   
Adtalem Global Education Inc. is a leading global education provider and the parent organization of Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine and Ross University School of Veterinary Medicine. These institutions offer a wide array of programs across medical and healthcare, and financial services.

Number of Employees: 4,426

 
 • Price / Volume Information   
Yesterday's Closing Price: $31.88 Daily Weekly Monthly
20 Day Moving Average: 451,901 shares
Shares Outstanding: 45.14 (millions)
Market Capitalization: $1,439.18 (millions)
Beta: 1.13
52 Week High: $40.23
52 Week Low: $19.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.94% 12.46%
12 Week 38.07% 52.22%
Year To Date 7.85% 29.19%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
500 WEST MONROE SUITE 28
-
CHICAGO,IL 60661
USA
ph: 866-374-2678
fax: 302-655-5049
chandrika.nigam@adtalem.com http://www.adtalem.com
 
 • General Corporate Information   
Officers
Lisa W. Wardell - Chief Executive Officer; Chairman and President
Robert J. Phelan - Interim Chief Financial Officer
William W. Burke - Lead Independent Director
Charles DeShazer - Director
Donna J. Hrinak - Director

Peer Information
Adtalem Global Education Inc. (BFAM.)
Adtalem Global Education Inc. (NLCI)
Adtalem Global Education Inc. (ATGE)
Adtalem Global Education Inc. (ITCC.)
Adtalem Global Education Inc. (LCGI)
Adtalem Global Education Inc. (APOL)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: SCHOOLS
Sector: Consumer Discretionary
CUSIP: 00737L103
SIC: 8200
Fiscal Year
Fiscal Year End: June
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/18/22
Share - Related Items
Shares Outstanding: 45.14
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.13
Market Capitalization: $1,439.18 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.28 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.25 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: 15.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/18/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 9.81
Trailing 12 Months: 10.84
PEG Ratio: 0.65
Price Ratios
Price/Book: 0.97
Price/Cash Flow: 6.23
Price / Sales: 1.05
EPS Growth
vs. Year Ago Period: 20.83%
vs. Previous Quarter: 16.00%
Sales Growth
vs. Year Ago Period: 30.28%
vs. Previous Quarter: -1.50%
ROE
03/31/22 - 10.99
12/31/21 - 10.93
09/30/21 - 11.09
ROA
03/31/22 - 4.20
12/31/21 - 4.16
09/30/21 - 4.73
Current Ratio
03/31/22 - 1.94
12/31/21 - 1.23
09/30/21 - 1.12
Quick Ratio
03/31/22 - 1.94
12/31/21 - 1.23
09/30/21 - 1.12
Operating Margin
03/31/22 - 10.76
12/31/21 - 11.01
09/30/21 - 12.05
Net Margin
03/31/22 - 23.34
12/31/21 - -0.51
09/30/21 - -0.09
Pre-Tax Margin
03/31/22 - -1.31
12/31/21 - 1.03
09/30/21 - 3.44
Book Value
03/31/22 - 33.03
12/31/21 - 25.88
09/30/21 - 25.42
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.82
12/31/21 - 1.24
09/30/21 - 1.26
Debt-to-Capital
03/31/22 - 45.10
12/31/21 - 55.42
09/30/21 - 55.87
 

Powered by Zacks Investment Research ©